In 1985 Simpson et al1 first described the percutaneous transluminal removal of atheromatous material from peripheral arteries by means of a novel catheter system. The technique was given the term "directional atherectomy," denoting the selective excision of obstructive luminal atheroma to distinguish it from surgical endarterectomy. Initial experience indicated that directional atherectomy could be performed safely and effectively and might be an attractive alternative to conventional balloon angioplasty in certain circumstances.2, 3 Developments in the atherectomy catheter and the design of suitable guiding catheters allowed the extension of the technique to the coronary arteries in 1986.4 Recently, directional coronary atherectomy has undergone comparison with coronary balloon angioplasty in a multicenter prospective, randomized trial, the CAVEAT study. After brief discussion of the technical aspects and clinical use of directional atherectomy, this article will focus on the application of atherectomy as a route to research.
TECHNICAL DETAILS
The Simpson AtheroCath (Devices for Vascular Intervention, Redwood City, Calif.) incorporates a rigid metal cylinder a short distance from the distal tip ( Fig. 1 ). This cylinder is windowed longitudinally on one side and carries an eccentric balloon on the other. Within the cylinder is a cup-shaped cutter that can travel the length of the window; the cutter is advanced and retracted by a hollow drive cable. The most distal part of the cylinder serves as a collection chamber. Proximally, the drive cable connects with a hand-held, battery-operated motor that spins at f 2,000 rpm. To position the Atherocath, a conventional 0.014-inch guide wire is passed through the cable lumen and manipulated across the lesion. The device can then be advanced. For coronary use preshaped, nonangled guiding catheters are first introduced. On retraction of the cutter, low-pressure inflation of the eccentric balloon holds the window firmly against the selected area of atherosclerotic plaque. Material intruding into the window is then shaved off and pushed into the collection chamber by the advancing cutter (Fig. 2) . After withdrawal of the device from the patient, specimens are flushed back into the window from where they can be extracted (Fig. 3) . The amount of tissue retrieved varies widely but from peripheral lesions approaches 100 mg in weight5 and from coronary lesions approximately 20
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CLINICAL APPLICATIONS
There is debate regarding the most appropriate niche for atherectomy in vascular intervention; several reports have focused on the therapeutic potential of the technique in peripheral and coronary arteries.2-41 7, 8 It is proposed that atherectomy may be advantageous in dealing with complex lesions often seen in unstable angina, where conventional balloon angioplasty can be associated with suboptimal results. Threatened or abrupt occlusion resulting from balloon-induced dissection can be managed by using directional atherectomy to excise the intimal flap, a bail-out role, but this is controversial. Originally, atherectomy was thought less likely to provoke restenosis on the basis of leaving a smoother vessel lumen with fewer dissections. This is probably not the case, but the increased initial luminal gain compared with conventional balloon angioplasty may better accommodate subsequent restenosis.
RESEARCH APPLICATIONS
Directional atherectomy has created the potential for new directions in both clinical and laboratory research (Fig. 4) . Indeed, among the new interventional devices, atherectomy is unique in providing the means to investigate pathophysiologic phenomena by using human vascular tissue. First, the tissue retrieved by the device can be subjected to histopathologic examination. Traditionally, the pathologic features of atherosclerosis in human beings have been studied by using material excised in the operating theater or autopsy suite. What directional atherectomy now offers is access to fresh vascular tissue for immediate fixation and examination in situations where precise details of the current and previous medical history and clinical investigations are available. Thus histopathologic appearances can be reliably related to different clinical pictures; primary atherosclerosis and restenosis, stable and unstable angina, for example.
Second, this tissue constitutes a source of cells for experimental work. Of necessity, investigations of mechanisms at cellular level in atherosclerosis, restenosis, and acute coronary syndromes have been performed in animal models to date. Studies have identified the vascular smooth-muscle cell as having a pivotal role in the response to injury of the vessel wall.' Smooth-muscle cells disaggregated or cultured from tissue excised at atherectomy can be examined with electron microscopy to identify subcellular organelles and myofibrils and with immunohistochemistry or electrophoresis to identify cytoskeletal proteins such as smooth muscle cell alpha-actin, to comment on cell phenotype. The distinction between the contractile and synthetic phenotypes of the vascular smooth-muscle cell in culture is shown diagrammatically in Fig. 5 1990;10:966.) vitro. Also, cultured human vascular cells may be used as experimental models in the assessment of pharmacologic agents and the investigation of genetic processes in the cell, including the effects of genetic manipulation. Third, tissue can be frozen pending characterization with molecular biologic techniques. Transcription, the process by which the genetic code is conveyed to the synthetic apparatus of the cell, and translation, the interpretation of the genetic message and consequent production of specific proteins (Fig.  6) ) can be unravelled by using monoclonal antibodies to recognize protein products and Northern blotting or in situ hybridization with selective radiolabeled gene probes to identify different messenger ribonucleic acid (RNA) chains (Fig. 7) .
Histopathologic studies. A number of reports have been generated by this aspect of directional atherectomy. Material excised from primary atherosclerotic lesions in peripheral vessels bore the typical appearance of dense, fibrous plaque with occasional cholesterol crystals. lo Two thirds of restenotic lesions in the periphery displayed the characteristic feature of the vascular response to injury, neointimal hyperplasia, but this feature was also found in approximately one third of primary lesions. lo, 'I Coronary artery histologic features were similar; virtually all restenotic lesions revealed neointimal hyperplasia, a feature seen nevertheless in a third of primary lesions.6 In our own series neointimal hyperplasia ( (Table 1 ). The presence of neointimal hyperplasia in a substantial proportion of primary atherosclerotic lesions is consistent with the suggestion that spontaneous intramural injury in the form of plaque rupture occurs commonly, often apparently without serious clinical consequence,12 and confirms that the primary atherosclerotic plaque is far from inert. What cannot yet be drawn from the literature is whether or not the primary atherosclerotic plaque demonstrating this evidence of vascular injury can distinguish subgroups of patients with a different pattern of symptoms, rapid onset or crescendo angina pectoris, for example.
Neointimal hyperplasia in plaque tissue testifies to recent or ongoing cellular proliferation. The proliferative status of intimal smooth muscle cells in fresh tissue obtained at directional atherectomy can be documented by using a monoclonal antibody to a cyclin, the proliferating cell nuclear antigen (PCNA), thus identifying cells in the S, Gi, and Gz phases of the cell cycle. l3 By this means a recent report confirmed that low rates of proliferation do exist in primary atherosclerotic lesions,14 in agreement with the histologic data regarding neointimal hyperplasia. In a brief series of patients undergoing directional atherectomy for restenosis in coronary and venous bypass graft stents, compared with patients receiving atherectomy for restenosis postballoon angioplasty, anti-PCNA labeling indicated that smooth-muscle cellular proliferation may wane within a relatively short period of time after coronary interventions: 47 days after stent implantation and 14 days after balloon angioplasty.'"
There is continuing interest in the role of thrombotic mechanisms in vascular events. In peripheral vessels adherent or incorporated thrombus was a common finding in relation to primary atherosclerotic lesions but less so in relation to restenotic lesions.lO, l1 Although thrombus was not commented on in a report of 73 coronary specimens6 a recent communication described the presence of thrombus in 18 of 19 complex coronary lesions.16 Our own group, examining 93 consecutive coronary atherectomy specimens, noted that the presence of organized thrombus within the plaque (Fig. 9 ) was related to unstable angina (Table I ). The proportion of cases was small, lo%, but in these patients the degree of organization of the thrombus allows us to estimate with some confidence that spontaneous plaque rupture took place 7 to 10 days previously. Given accurate clinical details, the comparison of primary atherosclerotic lesions demonstrating either organized thrombus or neointimal hyperplasia, with lesions showing neither of these features, provides fresh in- venous grafts and in already restenotic lesions but not in primary lesions. In material from 125 peripheral and 39 coronary procedures, observation of a highly cellular intima, identification of the internal elastic lamina and the presence of arterial media were found to be predictive of restenosis after atherectomy.18 Analysis of specimens from 377 coronary atherectomies revealed that the presence of lesion thrombus and incision into the adventitia were the two factors associated with procedural complications such as vessel occlusion, myocardial infarction, perforation and distal embolization in vein graftsi Information can also be obtained regarding other forms of vascular intervention. In 33 patients undergoing directional atherectomy for restenosis subsequent to balloon angioplasty, atherectomy, or laser angioplasty, Waller et a1.20 noted that the histologic appearances were similar regardless of the initial technique.20 The enterprising use of directional atherectomy in 21 patients immediately after either Nd:YAG ("hot-tip"), holmium:YAG, or excimer laser angioplasty allowed Isner et a1.21 to describe the pathologic effects of the three modes of laser, which ranged from charring several cell layers thick with the first to a mildly basophilic, serrated appearance, one cell layer deep with the last.21 Findings such as these may be useful when considering both the procedural result and the longer-term outcome of laser thermal and photoablation and may influence changes in clinical practice.
Studies using directional atherectomy are enhanced by the use of quantitative angiography where edge-detection analysis in particular provides useful information on plaque geometry in relation to both the effect of the procedurez2 and histopathologic data, Conceptually, the marriage of directional atherectomy and intravascular ultrasonography is very attractive. High-quality images of the vessel wall will help to assess the separate contributions of the three modes of action of the atherectomy device: the "Dotter" effect, the effect of balloon inflation, and the effect of the cutter. Also, examination of tissue retrieved may prove useful in corroborating the information provided by intravascular ultrasonography with regard to the components and architecture of the vessel wall. In a similar manner, different types of thrombus, or features of the plaque such as fissuring, revealed by angioscopy, can be sought in atherectomy samples.
Cell and cell culture studies. Bauriedel et a1.23 were the first to embark on cell-based investigations with atherectomy material and demonstrated that cells disaggregated from atherectomy specimens could be identified as smooth-muscle cells by their staining with monoclonal antibodies to smooth-muscle cell alpha-actin. 23 An extension to this work included electron microscopic and electrophoretic studies of peripheral arterial atherosclerotic material.24 The mixed phenotype of the intimal smooth-muscle cells (Fig. 5) , revealed by the presence of peripheral myofilaments together with dense perinuclear organelles, was consistent with the findings of studies of vascular injury in experimental animal models, and the distribution of cytoskeletal proteins, predominantly beta-, alpha-and gamma-actin and vimentin was similar to that found in studies of surgically excised human tissue. Immunofluorescence microscopy applied to sections of tissue obtained from coronary arteries at atherectomy revealed that vimentin-positive smooth-muscle cells of synthetic phenotype were also positive for cytokeratins 8 and 18.25 Cytokeratins are proteins found in fetal and neonatal but not adult vascular smooth-muscle cells, indicating that a subset of the coronary lesion smoothmuscle cells in this study had the characteristics of immature, dedifferentiated cells commonly associated with proliferative properties.
The material obtained at directional atherectomy can be exploited by using the technique of cell culture in the further use and investigation of the small pieces of tissue retrieved. Bauriedel et a1.23 were also the first to describe the cultivation of fibroblast-like cells from atherectomy tissue explants.23 It was subsequently reported that cells isolated from primary atherosclerotic and restenosing lesions in both peripheral and coronary arteries behaved differently in initial cell culture and early subculture.26, 27 Restenosis cells demonstrated more rapid growth, attributed to a significant subpopulation of small, low-adhesive proliferative cells that featured less among the cells of primary atherosclerotic origin. Two other findings were of particular interest. First, primary cells in culture did not respond to platelet-derived growth factor (PDGF), whereas restenosis cells responded by increasing their growth. Second, primary lesion cells proliferated in response to medium conditioned by restenosis cells, allowing the authors to propose an autocrine growth-promoting (non-PDGF) function of smooth-muscle cells in restenosis lesions in human beings, a mechanism previously suggested in animal studies. In a more recent study, this group describes their examination of cells cultivated from peripheral and coronary primary atherosclerotic and restenotic lesions by using a computer-assisted cell motion analysis system.5 Cell outgrowth was not related to any clinical parameter, including the type of lesion, but restenosis cells were found to display increased migratory activity during initial outgrowth in culture (Table II) , which in conjunction with their earlier findings regarding proliferation, led the authors to emphasize the importance of these aspects of cell behavior in the restenosis process.
Our own group has also sought to use initial and extended cell culture as a means of examining the behavior of human coronary smooth-muscle cells obtained at directional atherectomy. Confluent cells cultured from retrieved tissue and electron micrographic images of these cells reveal appearances consistent with a mixed contractile/synthetic phenotype (Fig. 10) . In agreement with the report of Dartsch et a1.26 with respect to peripheral vascular lesions, we found that smooth-muscle cells cultured from restenotic coronary lesions demonstrated accelerated growth compared with cells from primary atherosclerotic coronary lesions that had a growth pattern similar to young control human umbilical artery medial cells (Fig. 11) . Although we were also unable to relate growth in culture to any clinical parameter, a factor favoring successful initial smooth-muscle cell outgrowth was the presence of organized thrombus in the atherectomy specimen (Table III) , hinting at links between complex lesions, unstable angina, and restenosis. Further, coronary cells derived from both types of lesion demonstrated increased extracellular matrix production compared with the umbilical artery cells27 (Table IV) , consistent with the concept that extracellular matrix synthesis is a property of the adult vascular smooth-muscle cell important in both primary atherosclerosis and restenosis.
Cultured human vascular cells provide us with new alternative experimental models for the assessment of the in vitro actions of existing therapies and, potentially, for the development of novel treatment strategies. Having previously noted that material retrieved from patients receiving angiotensin-converting enzyme inhibitors was less likely to demonstrate successful smooth-muscle cell outgrowth,2g Bauriedel et a1.30 showed recently by means of cell motion analysis and cell population doubling times that two aspects of smooth-muscle cell growth in culture, migration, and proliferation responded similarly but to different extents to a variety of exogenous pharmacologic agents. The combination of photosensitizing hematoporphyrin derivatives and photoradiation, a potential means of localizing and attacking the atherosclerotic plaque, has been examined by using smooth-muscle cells cultured from tissue retrieved during peripheral arterial atherectomy.31 These cells were found to be more susceptible to damage than control vascular smooth-muscle cells cultured from healthy arteries biopsied postmortem. Cell-culture models need not be restricted to monolayers of one particular cell type. Coculture systems, as recently reviewed by Betz,32 can be constructed to mimic the vessel wall and thus cater for important interactions such as those that occur between the endothelium and the media.
"Gene therapy",33 whereby new genetic material is introduced to the cell by using methods such as lipofection,34 retroviral vectors,35 engineered cells,36, 37
and even particle bombardment,38 is a source of considerable current interest. Cells in culture may be Collagen synthesis was determined by the uptake of tritiated proline and sulphated-glycosaminoglycan synthesis by the incorporation of 35 sulphate. Values are nanomols of ligand per microgram of total protein, mean + SEM; L3 p < 0.05, *p < 0.005. used to evaluate the success and effects of attempts to modify the genome and influence translation and transcription; human vascular cells obtained at atherectomy are a logical preliminary testing ground.
Frozen tissue studies. The recent publication of Leclerc et a1.3g focuses on transcription (Fig. 6 ) and reports the increased expression of messenger RNA for nonmuscle myosin heavy chain-B (MHC-B) in the intimal smooth-muscle cells of restenosis tissue compared with primary atherosclerotic tissue retrieved at peripheral or coronary atherectomy.3g This finding is of interest because nonmuscle myosin has been implicated in vascular smooth-muscle cell division and proliferation; the method is a timely reminder of the application of molecular biologic techniques in clinical science. The mRNA for MHC-B was detected by in situ hybridization (Fig. 7) by using an antisense complementary (c)RNA probe prepared from recently cloned complementary deoxynibonucleic acid (DNA) coding for an isoform of the human nonmuscle MHC-B gene. To control for the specificity of the antisense cRNA probe, parallel hybridizations were performed with the sense cRNA probe; to control for cross-hybridization of the nonmuscle myosin probe to smooth-muscle myosin, hybridizations were performed in normal human internal mammary artery media preparations. By using a similar technique, this research group has now in- 
PROSPECTS
The various research techniques we have mentioned are unlikely to excite the cell biologist, who is well acquainted with them. However, with the advent of directional atherectomy, it is now possible to apply such techniques in a systematic manner to the investigation of atherosclerosis, our most common source of mortality, and restenosis, the response to injury that besets vascular intervention, by using human material. The identification of pathophysiologic mechanisms within the cell holds out the prospect of discovering, developing, and testing new pharmacologic or genetic therapies that can then be assessed in human cell culture systems. Work of this nature represents an important advance at a time when, in the field of restenosis, the failure of both empiric drug trials and trials based on apparently 
